Pakistan reviews IFPMA Code of Ethics
A seminar to discuss the International Federation of Pharmaceutical Manufacturers and Associations' Code of Ethics (Marketletter February 26) has been organized in Karachi, Pakistan, by the Pharma Bureau of the Overseas Investors Chambers of Commerce and Industry, according to a report in The Times of Pakistan.
Salman Bureny, the president of the OICCI and chief executive of the local subsidiary of UK-headquartered drug major GlaxoSmithKline, opened the meeting, noting that the drug industry is "vital" for humanity and must have ethical limits on its marketing practices. The Code of Ethics was presented to the gathering by Tajamul Hussain, general manager of Merck Masker Pakistan.
The guest of honor, the Director General Health from the Pakistan Ministry of Health, Shahida Malik, said: "I am glad to see such attendance from the member companies of the Pakistan Pharmaceutical Manufacturers Association, reflecting the extent of interest that the pharma industry is taking. We must keep the interest of the patients in mind, and work with integrity, credibility and quality."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze